🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 00688A106
- Market Cap
- Micro Cap
- IPO
- 7/27/2018 · $5.00/unit
Business: Adial Pharmaceuticals, Inc is a clinical-stage biopharmaceutical company focused on the development of a therapeutic agent for the treatment of alcohol use disorder using its lead investigational new drug product, AD04, a selective serotonin-3 antagonist (i.e., a 5-HT3 antagonist).
Company Contact
- CEO
- Cary J. Claiborne
- CFO
- Vinay Shah
- Headquarters
- 4870 Sadler Road, Suite 300, Glen Allen, VA 23060
- Phone
- 804-487-8196
- Investor Relations
- David Waldman, Crescendo Communications, LLC · 212-671-1020 · dwaldman@crescendo-ir.com